Expression of peroxisome‐proliferator activated receptor‐gamma (PPARγ) and the PPARγ co‐activator, PGC‐1, in human breast cancer correlates with clinical outcomes
暂无分享,去创建一个
[1] A. Badawi,et al. Expression of cyclooxygenase‐2 and peroxisome proliferator‐activated receptor‐γ and levels of prostaglandin E2 and 15‐deoxy‐Δ12,14‐prostaglandin J2 in human breast cancer and metastasis , 2003 .
[2] S. Kawa,et al. Peroxisome proliferator‐activated receptor γ ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines , 2002 .
[3] Susan M. Kilroy,et al. PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. , 2002, The Journal of clinical investigation.
[4] Xin Wang,et al. Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells , 2002, Molecular and Cellular Endocrinology.
[5] Miyuki Yamamoto,et al. Thiazolidinedione, a peroxisome proliferator-activated receptor-γ ligand, modulates the E-cadherin/β-catenin system in a human pancreatic cancer cell line, BxPC-3 , 2002 .
[6] A. Badawi,et al. Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma (Review). , 2002, International journal of oncology.
[7] S. Kawa,et al. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines. , 2002, Cancer.
[8] Miyuki Yamamoto,et al. Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, modulates the E-cadherin/beta-catenin system in a human pancreatic cancer cell line, BxPC-3. , 2002, International journal of oncology.
[9] T. Hansen,et al. Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus , 2001, Diabetologia.
[10] M. Pignatelli,et al. The peroxisome proliferator-activated receptor gamma is an inhibitor of ErbBs activity in human breast cancer cells. , 2001, Journal of cell science.
[11] W. Jiang,et al. Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model. , 2001, Biochemical and biophysical research communications.
[12] I. Pass,et al. Tumor suppressor and anti-inflammatory actions of PPARγ agonists are mediated via upregulation of PTEN , 2001, Current Biology.
[13] Michael Brownlee,et al. Inhibition of Cellular Proliferation through IκB Kinase-Independent and Peroxisome Proliferator-Activated Receptor γ-Dependent Repression of Cyclin D1 , 2001, Molecular and Cellular Biology.
[14] R. Roylance,et al. Multiple ways of silencing E‐cadherin gene expression in lobular carcinoma of the breast , 2001, International journal of cancer.
[15] K Ohta,et al. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells. , 2001, The Journal of clinical endocrinology and metabolism.
[16] Takuji Tanaka,et al. Troglitazone, a Ligand for Peroxisome Proliferator‐activated Receptor γ Inhibits Chemically‐induced Aberrant Crypt Foci in Rats , 2001, Japanese journal of cancer research : Gann.
[17] Takuji Tanaka,et al. Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats. , 2001, Cancer research.
[18] Rajnish A. Gupta,et al. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. , 2001, Cancer research.
[19] The peroxisome proliferator-activated receptor gamma is an inhibitor of ErbBs activity in human breast cancer cells. , 2001, Journal of cell science.
[20] V K Chatterjee,et al. Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. , 2001, Molecular and cellular biology.
[21] S. Ishihara,et al. Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists , 2000, British Journal of Cancer.
[22] T. Okumura,et al. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells. , 2000, Cancer research.
[23] M. Carey,et al. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer. , 2000, Cancer research.
[24] B. Spiegelman,et al. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Neal,et al. Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] S. Loitsch,et al. PPAR-gamma is selectively upregulated in Caco-2 cells by butyrate. , 2000, Biochemical and biophysical research communications.
[27] H. Peterse,et al. p27kip1 expression in breast carcinomas: An immunohistochemical study on 512 patients with long‐term follow‐up , 2000 .
[28] M. Kondo,et al. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. , 2000, Biochemical and biophysical research communications.
[29] E. Simpson,et al. Peroxisome Proliferator-activated Receptor γ Ligands Inhibit Estrogen Biosynthesis in Human Breast Adipose Tissue: Possible Implications for Breast Cancer Therapy , 2000 .
[30] E. Williamson,et al. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions. , 2000, Journal of the National Cancer Institute.
[31] M. Kilgore,et al. Differential transcriptional activation of peroxisome proliferator-activated receptor gamma by omega-3 and omega-6 fatty acids in MCF-7 cells , 2000, Molecular and Cellular Endocrinology.
[32] T. Chang,et al. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer. , 2000, Cancer research.
[33] R. Mansel,et al. Peroxisome proliferator activated receptor-γ (PPAR-γ) mediates the action of gamma linolenic acid in breast cancer cells , 2000 .
[34] H. Peterse,et al. p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up. , 2000, International journal of cancer.
[35] M. Laville,et al. Cloning and mRNA tissue distribution of human PPARγ coactivator-1 , 1999, International Journal of Obesity.
[36] Y. Matsuzawa,et al. PPARgamma inhibits the expression of c-MET in human gastric cancer cells through the suppression of Ets. , 1999, Biochemical and biophysical research communications.
[37] M. Sporn,et al. A New Ligand for the Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ), GW7845, Inhibits Rat Mammary Carcinogenesis , 1999 .
[38] H. Esterbauer,et al. Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression. , 1999, Genomics.
[39] Guillaume Adelmant,et al. Activation of PPARγ coactivator-1 through transcription factor docking , 1999 .
[40] V. Seewaldt,et al. Peroxisome proliferator-activated receptor gamma activation in human breast cancer. , 1999, International journal of oncology.
[41] B. Spiegelman,et al. An adipogenic cofactor bound by the differentiation domain of PPARγ , 1999, The EMBO journal.
[42] M. Laville,et al. Cloning and mRNA tissue distribution of human PPARgamma coactivator-1. , 1999, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[43] P. Puigserver,et al. Activation of PPARgamma coactivator-1 through transcription factor docking. , 1999, Science.
[44] M. Sporn,et al. A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis. , 1999, Cancer research.
[45] P. Puigserver,et al. A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis , 1998, Cell.
[46] Peter J. Brown,et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ , 1997 .
[47] Barry M. Forman,et al. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ , 1997 .
[48] Herman Yeger,et al. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer , 1997, Nature Medicine.
[49] D. Horsfall,et al. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[50] J. Kononen,et al. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. , 1996, American journal of clinical pathology.
[51] R. Mansel,et al. Regulation of the Expression of E-Cadherin on Human Cancer Cells by γ-Linolenic Acid (GLA) , 1995 .
[52] W. Jiang,et al. Inhibition of hepatocyte growth factor-induced motility and in vitro invasion of human colon cancer cells by gamma-linolenic acid. , 1995, British Journal of Cancer.
[53] R. Mansel,et al. Regulation of the expression of E-cadherin on human cancer cells by gamma-linolenic acid (GLA). , 1995, Cancer research.
[54] J. Capone,et al. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[55] W. J. Brammar,et al. The ontogeny of peroxisome-proliferator-activated receptor gene expression in the mouse and rat , 1992, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[56] I. Issemann,et al. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators , 1990, Nature.
[57] R. Morimoto,et al. Identification of cytosolic peroxisome proliferator binding protein as a member of the heat shock protein HSP70 family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.